等待开盘 10-24 09:30:00 美东时间
-0.250
-0.88%
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
10-20 10:03
华尔街最受关注、且可能影响市场走势的研究评级报告现已汇总如下。以下是由 The Fly 整理的今日投资者需关注的重点评级动态。 五大评级上调 瑞银集团...
10-17 22:29
Morgan Stanley analyst Erin Wright initiates coverage on Option Care Health (NASDAQ:OPCH) with a Overweight rating and announces Price Target of $35.
10-17 19:55
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32
TD Cowen analyst Charles Rhyee initiates coverage on Option Care Health (NASDAQ:OPCH) with a Hold rating and announces Price Target of $30.
10-02 22:09
Deal activity will rise by 15% in 2026, according to Goldman Sachs. Strategist David Kostin says M&A activity will increase next year "alongside accelerating US economic growth, improving CEO confiden...
09-29 03:14
今日重点评级关注:Guggenheim:维持MBX Biosciences"买入"评级,目标价从44美元升至84美元;Oppenheimer:维持MBX Biosciences"跑赢大市"评级,目标价从38美元升至80美元
09-24 10:23
Barrington Research analyst Michael Petusky maintains Option Care Health (NASDAQ:OPCH) with a Outperform and maintains $38 price target.
09-23 23:21
Option Care Health, the nation's largest independent provider of home and alternate site infusion services, will participate in two upcoming investor conferences. The company will attend the Deutsche Bank Healthcare Summit in New York City from September 10 to 11, 2025, and the Jefferies Healthcare Services Conference in Nashville on September 30, 2025. A fireside chat at the Jefferies conference is scheduled for 1:15pm CT/2:15pm ET, with a webca...
08-25 20:05
Option Care Health (NASDAQ:OPCH) shares rose after Directors of the company bought about $1.6M worth of shares. David Golding, Timothy Sullivan, Harry Kraemer and Carter Pate bought a total of 57,750 ...
08-23 00:19